These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6191141)

  • 21. Evaluation of the antihypertensive effect of a beta-blocker with the aid of daily blood pressure profiles.
    Abetel G; Karly M; Genoud G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S77-9. PubMed ID: 2439827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of atenolol and bopindolol on circadian heart rate.
    Fitscha P; Meisner W; Tiso B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S51-4. PubMed ID: 2439821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Derkx FH; Mulder P; Schalekamp MA
    Clin Pharmacol Ther; 1987 Oct; 42(4):411-9. PubMed ID: 2889554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Harron DW; Goa KL; Langtry HD
    Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
    Yamashita K; Shigematsu K; Maeda T; Ishida Y; Niwa M; Ozaki M
    Nihon Yakurigaku Zasshi; 1989 Jan; 93(1):7-15. PubMed ID: 2565861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypotensive effect of bopindolol in pithed rats.
    Tanaka H; Takahashi S; Shigenobu K
    Gen Pharmacol; 1993 Mar; 24(2):373-5. PubMed ID: 8097742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patients.
    Van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
    Br J Clin Pharmacol; 1984 Jan; 17(1):86-8. PubMed ID: 6691892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
    Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
    Fitscha P; Meisner W; Brandstetter G; Tiso B
    Eur J Clin Pharmacol; 1988; 34(4):411-3. PubMed ID: 2900146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of bopindolol on left ventricular function during exercise in patients with coronary artery disease.
    Righetti A; Mérier G; Viquerat C; Ratib O; Rutishauser W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S39-41. PubMed ID: 2439817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
    Schiess W; Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S30-3. PubMed ID: 2439815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
    Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
    Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
    Welzel D; Bräutigam M
    Arzneimittelforschung; 1989 Apr; 39(4):499-503. PubMed ID: 2568838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S12-5. PubMed ID: 2439811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bopindolol: a new long acting beta-receptor antagonist; its effects on haemodynamics, and on the renin response to tilting.
    Turner DR; Goodwin FJ; Knight AR; Littlejohns DW; Sharman VL; Vere DW
    Br J Clin Pharmacol; 1984 Mar; 17(3):295-9. PubMed ID: 6143566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
    Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC
    Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of the blood pressure lowering effect of bopindolol (Sandonorm) in patients with mild and moderate hypertension].
    Zsáry A; Káldi N; Kállay K
    Orv Hetil; 1991 Sep; 132(39):2149-51. PubMed ID: 1681490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
    Carboni GP; Scardovi AB; D'Ermo M; Prati PL
    Br J Clin Pharmacol; 1991 Dec; 32(6):755-7. PubMed ID: 1685090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MIS (Multicentric Isradipine Study of antihypertensive therapy).
    Widimský J; Dzúrik R; Fetkovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
    Cor Vasa; 1992; 34(1):4-14. PubMed ID: 1363224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.